Dyadic Applied Biosolutions, BRIG BIO and Strive Nutrition announce strategic collaboration
DYAI•DYAI•DYAI•DYAI•Dyadic Applied Biosolutions, BRIG BIO and Strive Nutrition announced a collaboration to accelerate commercialization of precision-fermented alpha-lactalbumin for U.S. premium nutrition markets. Dyadic targets initial commercial availability of more than 10 metric tonnes after completing the GRAS process, targeted for early 2028, and long-term annual production above 200 metric tonnes.
Dyadic Applied Biosolutions, BRIG BIO and Strive Nutrition announced a strategic collaboration to accelerate commercialization of precision-fermented alpha-lactalbumin for premium nutrition markets in the U.S. Dyadic targets initial commercial availability of more than 10 metric tonnes after the GRAS process, which it aims to complete in early 2028.
Dyadic International targets long-term production scale of more than 200 metric tonnes annually.
